The purpose of the study was to study the role of cytokines and major interferons in children with laryngeal papillomatosis in the dynamics of antiviral therapy in the postoperative period. To achieve this goal, 252 children with laryngeal papillomatosis aged 3 to 9 years were examined. All children were examined and treated in the surgical department of otolaryngology of TMA. In order to determine the effectiveness of the treatment of children, the following division into groups was carried out: Group I - children with a continuously recurrent course of papillomatosis of the larynx were divided into two subgroups: Subgroup I - the comparison group received standard treatment surgery + IFN preparations (reaferon) - one course per 28 days; Subgroup I - study group surgery + IFN preparations (alpha-IFN / inosine) - according to the scheme for 1 year. Group II - children with a frequently relapsing course of PH: II a subgroup - received standard treatment surgery + IFN preparations (reaferon) - one course for 28 days; II in the subgroup - surgery + IFN preparations (alpha-IFN / inosine) - according to the scheme for 6 months. Group III - children with a rarely recurrent course of PH: III a group - surgery; Group III - surgery + licopid. It was revealed that the analysis of the main interferons and cytokines of the immune system made it possible to establish that the changes obtained in a comparative analysis of clinical variants of laryngeal papillomatosis are amenable to immunotropic therapy, which is expressed by the use of an antiviral drug. Moreover, there is an improvement in the values of cytokines and interferons, which is expressed in a decrease in the production of pro-inflammatory cytokines and in an increase in the production of IFN-α and IFN-γ, which have pronounced antiviral properties. The clinical result of therapy was a decrease in the number of recurrences of papillomatosis in children, an improvement in general well-being, and clinical and laboratory indicators of the disease.

papillomatosis of the larynx in children, interferons, cytokines

Garashchenko T.I. Study of immunological parameters in children with laryngeal papillomatosis and possible ways of immunocorrection // Vestn. otorhinolaryngitis - 1996. - No. 4. - S. 15-18.

Ershov F.I. Early cytokine responses in viral infections // Cytokines and inflammation. 2004. -T. 3, No. 1.-S. 3-7:

Novikov D.K., Vykhristenko L.R. et al. Immunology and allergology for JIOP doctors // M.: Med. information agency, 2006. -512 p.

Soldatsky Yu.L., Onufrieva E.L., Shchepin N.V. et al. Outcomes of juvenile respiratory papillomatosis // Ros. otorhinolaryngitis 2004. - V.11, No. 4. - S.70-73.

Karimova F.S. Treatment of papillomatosis of the larynx with interferon inducers // Materials on the effectiveness of the use of cycloferon in the clinic of ENT diseases. St. Petersburg: "Taktik-Studio", 2006. - S. 49-52.

Pluzhnikov M.S., Katinas E.B., Ryabova M.A. Clinical and immunological characteristics of recurrent respiratory papillomatosis // Ros. otorhinolaryngitis 2006. - V. 22, No. 3. - S. 22-26.

Pluzhnikov M.S. Immunotropic therapy in ENT practice // Handbook of immunotherapy for practice. doctor. SPb., 2002. - S. 392-401.

Sidorenko S.I. Interferon preparations and its inducers in the complex therapy of juvenile respiratory papillomatosis: Ph.D. dis. cand. honey. Sciences. M., 2001. - 21 p.

Soldatsky Yu.L. Diseases of the larynx // Pediatrician, Pharmacol.: scientific-practical. Journal of the Union of Pediatricians of Russia. 2008. - Volume 5; No. 3. -S. 28-31.

Armstrong LR, EJD Preston, M. Reichert et al. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle // Clin Infect Dis. 2000. - No. 31. - P. 107-109.

Goon R ., Sonnex C ., Jani R . et al. Recurrent respiratory papillomatosis: an overview of current thinking1 and treatment // Eur Arch Otorhinolaryngol. 2008.265(2).-P. 147-151.

Koutsky LA, Ault KA Wheeler et al. A controlled trial of a human papillomavirus type 16 vaccine // N. Engl. J. Med. 2002. - Vol. 347, No. 21. - P. 1645-1651.

McKenna M ., L. Brodsky. Extraesophageal acid reflux and recurrent respiratory papilloma, in children // Int J Pediatr Otorhinolaryngol. 2005. - Nk 69. - P. 597-605

Ruparelia C. , E. R. Unger, R. Nisenbaum et al. Predictors of remission in juvenile-onset recurrent respiratory papillomatosis // Arch-Otolaryngol Head Neck Surg. 2003. - No. 129 - P. 1275-1278.

Shikowitz M ., AL Abramson, BM Steinber et al Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis // Arch. Otolaryngol. Head Neck Surg. 2005. - Vol. 131, No. 2. - P. 99-105.